Filing Details
- Accession Number:
- 0001683168-24-002047
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2024-04-01 21:36:09
- Reporting Period:
- 2023-12-31
- Accepted Time:
- 2024-04-01 21:36:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1563577 | Galera Therapeutics Inc. | GRTX | () | 5 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486558 | E. Mark Pearson | 5960 Berkshire Ln Floor 6 Dallas TX 75225 | No | No | No | Yes | |
| 1745878 | Altamont Pharmaceutical Holdings, Llc | 5960 Berkshire Ln Floor 6 Dallas TX 75225 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-11 | 400,000 | $0.23 | 4,880,000 | No | 4 | S | Indirect | See fn. |
| Common Stock | Disposition | 2024-03-22 | 20,000 | $0.23 | 4,860,000 | No | 4 | S | Indirect | See fn. |
| Common Stock | Disposition | 2024-03-25 | 780,000 | $0.22 | 4,080,000 | No | 4 | S | Indirect | See fn. |
| Common Stock | Disposition | 2024-03-26 | 2,000,000 | $0.20 | 2,080,000 | No | 4 | S | Indirect | See fn. |
| Common Stock | Disposition | 2024-03-27 | 306,924 | $0.17 | 1,773,076 | No | 4 | S | Indirect | See fn. |
| Common Stock | Disposition | 2024-03-28 | 693,076 | $0.15 | 1,080,000 | No | 5 | S | Indirect | See fn. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See fn. |
| No | 4 | S | Indirect | See fn. |
| No | 4 | S | Indirect | See fn. |
| No | 4 | S | Indirect | See fn. |
| No | 4 | S | Indirect | See fn. |
| No | 5 | S | Indirect | See fn. |
Footnotes
- Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC ("Altamont"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares.
Billionaire Hedge Funds
